EQSAdhoc Eckert & Ziegler Strahlen und Medizintechnik AG Key word Contract Eckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium177 with POINT Biopharma 25Sep202
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): ContractEckert & Ziegler Signs Strategically Important Agreement for the Supply of Lutetium-177 with POINT Biopharma25-Sep-2023 / 23:17 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitte.
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract/AllianceEckert & Ziegler collaborates with RefleXion Medical and Telix Pharmaceuticals to Expand Treatment Options for Prostate Cancer Patients 13.09.2023 / 15:00 CET/CESTThe issuer is solely responsible for the content of this an.
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Half Year Report
Eckert & Ziegler Continues Positive Sales Development in the First Half of. -Today at 01:46 am- MarketScreener
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): ForecastEckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.21-Jul-2023 / 15:21 CET/CESTDisclosure of an insi.